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Background & objectives: Mycoplasma pneumoniae is the most important and common cause of 
community-acquired pneumonia (CAP). The conventional detection methods (culture and serology) lack 
sensitivity. PCR offers a better approach for rapid detection but is prone to carry over contamination 
during manipulation of amplification products. Quantitative real-time PCR (qRT-PCR) method offers 
an attractive alternative detection method. In the present study, qRT-PCR, PCR and serology methods 
were used to detect M. pneumoniae infection in cases of pneumonias and findings compared.
Methods: A total of 134 samples consisting of blood (for serology) and respiratory secretions (for PCR 
and qRT-PCR) from 134 patients were collected. The blood samples were tested for IgG, IgM and IgA 
using commercially available kits. For standardization of PCR of M. pneumoniae P1 gene was cloned 
in pGEMTEasy vector. Specific primers and reporter sequence were designed and procured for this 
fragment. The qRT-PCR assay was performed to prepare the standard curve for M. pneumoniae positive 
control DNA template and detection in patient samples.
Results: Of the 134 patients, 26 (19%) were positive for antibodies against M. pneumoniae. IgG was 
positive in 14.92 per cent (20) cases, IgM in 4.47 per cent (6) and IgA was positive in 5.22 per cent (7) 
cases. In the qRT-PCR assay 19 per cent (26) samples were positive. Of the 26 qRT-PCR positive samples, 
nine could be detected by serology. PCR was positive for 25 samples. An extra sample negative by PCR 
was detected by qRT-PCR. Thus, real-time PCR assay, PCR and serology in combination could detect 
M. pneumoniae infection in 43 patients.
Interpretation & conclusions: The study shows that 17 patients were detected by serology alone, 17 were 
detected by qRT-PCR only and nine patients were positive by both serology and real-time PCR. Of the 
134 samples tested, 25 were positive by conventional PCR, but qRT-PCR could detect one more sample 
that was negative by PCR and serology. These results suggest that a combination of two or three methods 
may be required for reliable identification of CAP due to M. pneumoniae.
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 Mycoplasma pneumoniae accounts for as many 
as 10-30 per cent of all cases of commonly acquired 
pneumonia (CAP)1 in general population and for 25-
71 per cent in closed populations2 such as students and 
military recruits living in dormitories. M. pneumoniae 
has been frequently observed in patients suffering with 
respiratory illness and is also reported to be associated 
with acute exacerbation of bronchial asthma and 
chronic obstructive pulmonary disease (COPD)3, acute 
respiratory distress syndrome (ARDS)4, polyarthritis5, 
stroke6, Guillain-Barre syndrome7, and coronary artery 
diseases (CAD)8.
 Infections caused by M. pneumoniae have been 
recognized worldwide. Earlier infections with M. 
pneumoniae were generally reported to be affecting 
people between the age of 5 and 25 yr. The incidence 
of M. pneumoniae pneumonia requiring hospitalization 
increases with age, highlighting the importance of this 
pathogen in the elderly hospitalized with pneumonia. 
Clinically M. pneumoniae pneumonia cannot be 
differentiated from pneumonia caused by other bacteria 
and viruses. Mycoplasma infection in India has been 
reported for 35 per cent patients with community 
acquired pneumonia in both children as well as in 
adults9. M. pneumoniae can produce a wide range of 
clinical symptoms ranging from pneumonia, bronchitis, 
upper respiratory disease to inapparent infections.
 M. pneumoniae grows slowly in culture and can 
take weeks to grow1,10. Thus, it is difficult to carry out 
culture analysis for routine diagnosis. Diagnosis of 
M. pneumoniae infection still relies on conventional 
serological procedures; however, these are generally 
non-specific and lack sensitivity. Molecular diagnosis 
by PCR assays have been described for the detection 
of M. pneumoniae. Targets reported for PCR are P1 
gene11,12, 16SrRNA13 and Tuf gene encoding elongation 
factor Tu14,15. Real-time PCR16-18 based assays targeting 
some of the above mentioned genes have been described 
and have an advantage over conventional PCR in terms 
of sensitivity and specificity19,20. In the present study, 
a P1 gene based, real-time PCR assay was employed 
to detect M. pneumoniae infections among Indian 
patients. Further, conventional PCR and detection of 
all immunoglobulin classes (IgG, IgM & IgA) were 
also attempted and results were compared.
Material & Methods
Strain and samples: Standard strain of M. pneumoniae 
M129 was procured from ATCC, USA. A total of 134 
clinical samples consisting of blood and respiratory 
tract fluids (107 throat swabs, 19 nasopharyngeal 
aspirates, 6 endotracheal aspirates, and 2 broncoalveolar 
lavage) were collected between May 2005 and August 
2008 from the patients diagnosed to have CAP and 
admitted at medicine & paediatrics wards of All 
India Institute of Medical Sciences (AIIMS), New 
Delhi, India. Serum extracted from blood samples and 
respiratory tract fluids was stored at -20°C until use. 
The study protocol was approved by the Institute’s 
ethics committee. Patients included in the study were 
based on the following criteria:
Inclusion criteria: (i) Community acquired pneumonia 
(CAP): Presence of at least one of the major clinical 
criteria (cough, sputum production, fever > 37.8°C) or 
two of the minor criteria (pleuritic chest pain, dyspnoea, 
altered mental state, sign of pulmonary consolidation 
on examination or total leukocyte count of 12000/µl). 
 (ii) Presence of a new pulmonary infiltrate/ shadow 
on chest X-ray suggestive of pneumonia at/ within 24 h 
of hospitalization. 
 (iii) Patient residing in community.
Exclusion criteria: (i) Hospital acquired pneumonia i.e. 
pneumonia that developed 72 h after hospitalization or 
within 7 days of discharge. 
 (ii) Pulmonary shadow due to a cause other than 
pneumonia.
 All patients fulfilling the inclusion criteria were 
included. 
Culture: The M. pneumoniae standard strain was 
revived according to ATCC guidelines (www.atcc.org). 
In brief, the lyophilized culture was resuspended in 6 
ml pleropnemonia like organism (PPLO) broth. A single 
drop was used to inoculate PPLO agar; 3 ml suspension 
was used to prepare glycerol stocks and stored at -70°C. 
The remaining 3ml suspension was incubated at 37°C 
and 5 per cent CO2 incubator till growth was observed 
with change in colour from red to yellow. 
Genomic DNA: PPLO broth culture or samples in 
PPLO broth after colour change to yellow were used 
for genomic DNA extraction. Culture (200 µl) was 
centrifuged at 22,000 g for 15 min to pellet the cells. 
The pellet was washed with PBS (pH 7.2). After 
washing twice, pellet was resuspended in 100 µl 
autoclaved double distilled water. Tubes were placed 
in boiling water bath for 10 min and then centrifuged 
for 30 sec to sediment the debris21,22. The supernatant 
was collected in new micro-centrifuge tubes and stored 
at -20°C until used.
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PCR and positive control preparation: For M. 
pneumoniae P1 adhesin gene specific primers were 
used (Table I). The target sequence for amplification 
was a 543 bp segment of the gene coding for P1 
adhesin protein. The 25 µl PCR reaction consisted 
of 1X PCR buffer (Bangalore Genei, India), 1.5 mM 
MgCl2 (Bangalore Genei, India), 200 µM dNTPs (MBI 
Fermentas, USA ), 20 pmol of each primer (Sigma-
Aldrich, USA), 1 Unit of Taq polymerase (Bangalore 
Genei, India) and 5 µl of extracted genomic DNA. 
The reaction was performed in a thermocycler (Perkin 
Elmer, USA). The target sequence for amplification was 
a 543bp fragment of the P1 gene and PCR was done as 
described earlier23. In brief, PCR run consisted of 35 
cycles of amplification, each at 94°C for 1 min, 55°C for 
1 min and 72°C for 2 min and final elongation step of 10 
min at 72°C. A negative control was systematically run 
in parallel. This method was used for PCR amplification 
from patient samples. The 543 bp PCR product from 
M. pneumoniae M129 (ATCC, USA) standard strain 
was cloned in pGEM-T Easy (Promega, USA) vector 
according to manufacturer’s instructions. The positive 
clone was confirmed by restriction digestion and 
sequencing. This clone was used subsequently as a 
positive control for standardization of M. pneumoniae 
PCR and real-time PCR assay by serially diluting the 
plasmid.
Quantitative real-time PCR assay: The clone once 
confirmed by sequencing was used to extract DNA in 
large quantity. For this, a 100 ml Luria Bertani (LB) 
broth containing ampicillin (100 µg/ml) was inoculated 
with the glycerol stock. The culture was incubated at 
37°C in a shaker. The overnight grown culture was 
harvested and the plasmid extraction was done using 
the Qiagen Midi kit (Qiagen, USA). The plasmid 
DNA extracted was quantified spectrophotometrically. 
The final concentration of the plasmid DNA was 
575 ng/µl. The copy number calculation was done 
using the following formula:
Copy number = 
MW (g/mol)
6.023 x 1023 (copies/mol) ×  
Concentration of standard (g/µl)
 Conc. of std- Obtained spectrophotometrically
 MW- Molecular weight of each pGEM-T Easy plasmid with 
cloned gene.
 Using the above formula M. pneumoniae P1 gene 
cloned in pGEM-T Easy vector was calculated to be 
14x1010 copies/µl and a set of dilutions were prepared 
for standard curve preparation. The primers for real 
time assay were synthesized corresponding to a 73 
bp fragment internal to the 543 bp fragment of P1 
gene which is detected by Fam-dye labelled reporter 
sequence. These primers and reporter sequences 
(Table I) were synthesized by Applied Biosystems, 
USA. Along with the positive reactions of dilutions 
of template DNA, a no-template control (NTC) was 
also included. The reactions were performed in a 
final volume of 20 µl containing 1 µl 20X assay 
mix (primers & probe), 10µl 2x TaqMan® Universal 
Master Mix (enzyme, buffer & dNTPs) and 9 µl DNA 
diluted in RNase free water. Amplification and product 
detection were performed with the ABI PrismTM 7700 
Sequencing Detection System, USA. Once the reaction 
for standard curve was finalized, similar reactions were 
performed for DNA extracted from patients’ throat 
swab samples.
Serology: Serum was separated from the venous 
blood samples and stored at -20°C till assayed. Serum 
specimens collected in acute phase from patients were 
used to detect IgM, IgA and IgG antibodies against M. 
pneumoniae by commercial ELISA kits (Verion/Serion, 
Germany). A titre of IgG >30 U/ml, a titre >1.1RU of 
IgM and a titre > 14 U/ml of IgA were considered as 
positive. 
Statistical analysis: Fisher exact and Pearson Chi 
square tests were used to analyse clinical signs and 
symptoms and demographic data (age & sex).
Results
Demographic profile: A total of 134 patients were 
enrolled in the study. Of these, 92 (69%) were males 
and 42 (31%) were females. The patients positive 
for M. pneumoniae by any test (serology, PCR and 
real-time PCR) consisted of 27 (29%) males and 16 
(38%) females. The study group included 37 (28%) 
paediatric and 97 (72%) adult patients. There were 6 
Table I. PCR and real-time PCR primers for P1 adhesin gene 
of M. pneumoniae
PCR
Forward primer: 5’ CAAGCCAAACACGAGCTCCGGCC 3’
Reverse primer: CAGTGTCAGCTGTTTGTCCTTCCCC-3’
Real-time PCR
Forward primer: 5’ AACCTCGCGCCTAATACTAATACG 3’
Reverse primer: 5’ TTGCGGCGTTGCTTTCAG 3’
Reporter sequence: 5’ Fam-AAAGTCGACCAACCCC-NFQ 3’
FAM, 6-caboxyfluorescein
Synthesized by Applied Biosystems, USA
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(16%) paediatric and 37 (38%) adult patients positive 
for M. pneumoniae by any test done in the study. M. 
pneumoniae positivity using serology and qRT-PCR 
in different age groups is given in Table II. Overall, 
real-time PCR assay, PCR and serology in combination 
could detect M. pneumoniae infection in 43 patients.
PCR and positive control preparation: The M. 
pneumoniae standard strain maintained in the 
laboratory was used for genomic DNA extraction. 
The genomic DNA extracted was used for PCR 
amplification of 543bp fragment of P1 gene (Fig. a). The 
PCR amplified product was cloned in pGEM-T Easy 
Table II. Age distribution for M. pneumoniae positive 
(serology & qRT-PCR) and negative patients
Age group 
(yr)
M. pneumoniae 
+ve
M. pneumoniae 
-ve
Total 
patients
 0-15 6 31 37
16-30 10 18 28
31-45 5 6 11
46-60 10 18 28
61-75 11 17 28
76-90 1 1 2
Total 43 91 134
vector and confirmed by restriction digestion (Fig. b) 
and sequencing. This clone was used subsequently as a 
positive control for standardization of M. pneumoniae 
PCR and real-time PCR assay. A total of 25 patients 
were found positive for conventional PCR.
Real-time PCR: In the qRT-PCR assay for M. 
pneumonia, standard curve was obtained using P1 
gene cloned in pGEM-T Easy vector as positive 
control. The cycle threshold (CT) values obtained for 
different dilutions of control plasmid were in the range 
of 10-31 for concentration range of 90 to 9×108 copies/
reaction. The minimum detection limit was found to 
be 90 copies/reaction. The sensitivity and specificity 
of M. pneumoniae real time PCR assay were 34.6 and 
84.2 per cent, respectively. Patient samples using DNA 
extracted from respiratory secretions (throat swabs, 
nasopharyngeal aspirates, endotracheal aspirates 
and broncoalveolar-lavage) were tested with the 
standardized assays. A total of 26 (19%) samples were 
found to be positive out of 134 patient samples by real-
time PCR assay.
Serology: Of the 134 patients, 26 were positive for any 
class of immunoglobulins by ELISA; of these, IgG 
was positive in 20 (14.92%) cases, IgM was positive 
in 6 (4.47%) cases and IgA was positive in 7 (5.22%) 
cases. Combination of IgG+IgM+IgA were positive in 
2, IgG+IgM in 2 and IgG+IgA in 1 patient.
Fig. a. PCR amplification of P1 gene fragments for positive control preparation. Lane M: 1 kbp ladder, lane 1: P1 gene 543 bp positive PCR, 
lane 2: no template control. b. Restriction digestion of positive clones. Lane M: 1 kbp ladder, lanes 1-4: positive clones. 
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Clinical signs and symptoms: The comparison of 
clinical data of CAP patients diagnosed for M. 
pneumoniae based on qRT-PCR assay and serology 
(Table III), revealed that fever, cough, headache and 
dyspnoea were equally positive in both the groups. Of 
the clinical signs crepitations and pleural rub (Table 
III) was higher in serology positive cases though it 
was not significant. Wheeze, decreased breadth sounds 
and significant chest X-ray were equally positive in 
both the groups. The clinical signs and symptoms for 
M. pneumoniae positive (serology and qRT-PCR) and 
M. pneumoniae negative patients did not show any 
significant difference (Table IV). 
Discussion
 Many bacterial and viral infections often share 
clinical features and symptoms which are difficult 
to distinguish clinically24,25. A sensitive and effective 
method of detecting these agents is required so that 
the correct treatment is offered and unnecessary use 
of antibiotics can be avoided. The standard laboratory 
method for the diagnosis of M. pneumoniae as an 
aetiological agent for CAP has been the culture 
or serology26. PCR has been shown to be a better 
diagnostic test than conventional techniques19,27. Real-
time PCR significantly reduces time to give results and 
has an advantage over conventional PCR as detection 
is performed in a closed system in real time, thus 
minimizing the risk of contamination. In the present 
study, a real-time PCR assay that targets the P1 adhesin 
gene for the diagnosis of M. pneumoniae infections 
was performed along with serology and conventional 
PCR. Based on P1 gene detection, qRT-PCR assay 
was developed to detect M. pneumoniae infections 
in 134 patients. Using both qRT-PCR and serology, 
overall 43 (of the 134) patients (32.08%) were found 
positive. qRT-PCR was positive in 26 of the 134 
(19.4%) samples as compared to conventional PCR 
Table IV. Clinical symptoms and signs for serology and real-time PCR positive patients for community acquired pneumonia
Clinical signs Serology
N=26 (%)
Real- time PCR 
N=26 (%)
Clinical  
symptoms
Serology 
N=26 (%)
Real- time PCR
N=26 (%)
Pleural rub 3 (11.5)  0 (0)  Fever 18 (69) 20 (77)
Wheeze 5 (19) 6 (23) Cough 23 (88) 23 (88)
Crepitations 16 (61.5) 11 (42) Headache 1 (4) 1 (4)
Bronchial breathing 1 (4) 2 (8) Vomiting 4 (15) 0 (0)
Whispering pectoriloquy 0 (0) 0 (0) Abdominal pain 3 (11.5) 1 (4)
Decreased breath sounds 3 (11.5) 3 (11.5) Diarrhoea 5 (19) 4 (15)
Significant chest X-ray 25 (96) 26 (100) Dyspnoea 14 (54) 16 (61.5)
Nine patients were positive for both serology and RT-PCR
Table III. Clinical signs & symptoms of M. pneumoniae positive [serology (n=17) & qRT-PCR (n=17) and positive for both (n=9)] and 
negative patients for community acquired pneumonia. 
Clinical signs M. pneumoniae 
positive  
N=43
(%)
M. pneumoniae 
negative
N=91
 (%)
Clinical  
symptoms
M. pneumoniae 
positive
N=43
(%)
M. pneumoniae 
negative
N=91
 (%)
Pleural rub 2 (5) 4 (4.5)  Fever 32 (74.5) 77 (85)
Wheeze 9 (21) 11 (12) Cough 39 (91) 77 (85)
Crepitations 22 (51) 44 (48.5) Headache 2 (5) 9 (10)
Bronchial breathing 4 (9) 8 (9) Vomiting 4 (9) 13 (14)
Whispering pectoriloquy 0 (0) 1 (1) Abdominal pain 3 (7) 6 (7)
Decreased breath sounds 3 (7) 0 (0) Diarrhoea 8 (19) 11 (12)
Significant chest X-ray 42 (98) 91 (100) Dyspnoea 27 (63) 58 (64)
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in 25 of the 134 samples tested. However, 17 cases 
positive by qRT-PCR were negative by serology (Table 
V). Serology showed 17 samples positive which were 
negative by qRT-PCR was negative. Of these 17 cases, 
only IgG antibody was detected in 11 cases whereas 
IgA and IgM were absent. In these cases the presence 
of IgG antibodies alone can be due to past infection 
and, therefore, real-time PCR missed only six cases of 
acute infection where IgA/IgM was also detected. 
 Our study showed that clinical signs like pleural rub 
and crepitations were more in serology positive patients 
compared to sero negatives though not significantly. 
Tempelton et al28 reported that none of the patients with 
M. pneumoniae infections had pulmonary diseases in 
contrast majority of patients in our study were observed 
with pulmonary disease. Clinical signs and symptoms 
among M. pneumoniae positive (serology and qRT-
PCR) and negative patients were also compared, but no 
significant difference was observed. This suggests that 
M. pneumoniae infection cannot be differentiated from 
other pulmonary infections on the basis of clinical signs 
and symptoms. Thus, for better patient management a 
laboratory diagnosis is important to detect or to rule out M. 
pneumoniae infection from other respiratory infections.
 Tempelton et al28 reported 12 (11%) positive results 
by qRT-PCR assay for M. pneumoniae infection in a 
group of 106 patients. Other studies have shown 20-21 
per cent positivity by qRT-PCR assay29,30. Our study 
showed 19.4 per cent (26/134) positive samples by qRT-
PCR assay and 18.6 per cent (25/134) by PCR which 
is close to the reported studies from other geographical 
locations. One additional case was picked by qRT-PCR 
Table V. Comparison of results of real-time PCR with conventional PCR and serology
RT-PCR positive patients CT value Copy No. IgG IgM IgA PCR
1. 15 1.3 × 106 - - - +
2. 18 1.8 × 105 - - - +
3. 21 1.1 × 104 - - - +
4. 24 1.4 × 104 - - - +
5. 24 1.3 × 104 - - - +
6. 24 1.3 × 104 - - - +
7. 24 1.3 × 104 - - - +
8. 24 1.2 × 104 - - - +
9. 24 3.6 × 103 - - - +
10. 24 3.4 × 103 - - - +
11. 25 7.3 × 103 - - - +
12. 25 6.3 × 103 - - - +
13. 25 6.3 × 103 - - - +
14. 25 2.9 × 103 - - - +
15. 28 4.5 × 103 - - - -
16. 28 3.6 × 103 - - + +
17. 28 2.5 × 103 - + - +
18. 28 2.4 × 103 + - - +
19. 28 2.2 × 103 - - - +
20. 28 1.7 × 103 + + + +
21. 29 2.0 × 103 + - - +
22. 29 1.9 × 103 + + - +
23. 29 1.5 × 103 + - + +
24. 29 1.5 × 103 + - - +
25. 29 1.1 × 103 - - - +
26. 30 9.0 × 102 + - - +
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which was negative by both PCR as well as serology.
 There were 17 samples positive by RT-PCR having 
high copy number but were not detected by serological 
test. All these cases were having clinical symptoms for 
less than one week duration. During early period of 
infection organism load is usually high in the throat 
swab sample but detectable amount of antibodies are 
not generated, and hence such samples are missed by 
serological methods.
 The merit of this study is that three different classes 
of antibodies, qRT-PCR and PCR have been done in 
all the cases, whereas none of the earlier studies have 
looked for IgA, IgM and IgG simultaneously in the same 
sets of samples. Thurman et al30 used real-time PCR 
and IgG/IgM antibody detection kit in the investigation 
of outbreaks of CAP due to M. pneumoniae and showed 
81 per cent positive results with IgM antibodies and 
54 per cent with IgG/IgM. Morozumi et al31 reported 
sensitivity and specificity of real-time PCR related to 
serological assay as 90.2 and 97.9 per cent of real-
time PCR positive samples. In our study although 
both PCR and qRT-PCR showed concordant results, 
serology was positive in only one third (9/26) of these 
cases, therefore, sensitivity and specificity of qRT-PCR 
compared to serological assay (ELISA) was 34.6 and 
84.2 per cent, respectively. As reported by Thurman et 
al30, the sensitivity of the real-time PCR assay reduces 
with the delay in collection of samples from the onset 
of the disease.
 In conclusion, our study indicated that no single 
available test was reliable for identification of M. 
pneumoniae infections. A combination of two or 
three methods can be the most reliable approach 
for identification of CAP due to M. pneumoniae, 
especially in the absence of other suspected respiratory 
pathogens. However, qRT-PCR may not only detect 
M. pneumoniae infection early in the course of disease 
but also quantitates bacterial load and helps to initiate 
specific antibiotic therapy. The qRT-PCR assay can be 
used to rule out infection with M. pneumoniae when 
the samples are tested for new emerging respiratory 
pathogens. 
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